Flowr Corporation CEO Tom Flow and Chairman of the Board and Chief Strategist Steven Klein were recently profiled on New Cannabis Ventures. The company is currently in the midst of building their flagship facility in Kelowna, British Columbia and intends to target the Canadian market as a new licensed producer.

The article talks about Flow’s extensive experience in the cannabis industry spanning a decade. “Under the MMAR program in Canada, he helped design and build 17 facilities in Ontario. When the MMPR (now ACMPR) program launched, he founded MedReleaf (since acquired by Aurora Cannabis), where he led the design, build, and operations of its original Ontario facility, which is regarded as one of the most efficient large-scale facilities in the country.”

The article further mentions the company’s production facility at Kelowna that is currently running at 20% of its production capacity at 2,500 kilos. When the entire facility is completed by year-end, the production capacity is expected to increase to 12,000 to 15,000 kilos per year. “The company is also in process of designing a number of other facilities, which will take Flowr’s annual production capacity to approximately 60,000 kilos.”

Not only is the company prepared to enter the active cannabis market in British Columbia, it has also been named one of the 31 initial suppliers in the province and has potential supply agreements lined up with a number of other provinces. Furthermore, the company is also gearing for an international expansion starting with an LOI with a German importer.

Flow attributes the company’s competitive edge to the fact that the company has been “built by growers for growers.” The company’s two brands: Flowr for the recreational space and Flowr Rx for the medical space are all set to meet the shortages for high quality products, which the company expects will be more severe once the legal retail market launches in the fall.

To read the full interview, click here.

Subsequent to this press release, The Flowr Corporation went public on September 26, 2018 under the ticker symbol TSXV:FLWR.

Source: www.newcannabisventures.com

In the evolving rush of mergers and acquisitions (M&A) in the Canadian cannabis market, Canopy Growth (NASDAQ:CGC,TSX:WEED) announced it will acquire The Supreme Cannabis Company (TSX:FIRE,OTCQX:SPRWF) in a deal worth approximately C$435 million.

Meanwhile, a cannabis operator in the US confirmed this week that it will receive a financial boost from a partner to solidify its position in the burgeoning Pennsylvania state market.

Keep reading... Show less

The Board of Directors of Aphria Unanimously Recommends Shareholders Vote “For” the Arrangement

Aphria to Host Special Meeting of Shareholders on Wednesday, April 14, 2021 to Approve Proposed Aphria-Tilray Business Combination

Keep reading... Show less

Love Hemp Group PLC (AQSE: LIFE) (OTCQB: WRHLF), one of the UK’s leading CBD and Hemp product suppliers, announces that as part of the equity fundraise announced yesterday, Antony Calamita and Andrew Male, Directors of the Company, subscribed for 285,714 Ordinary Shares and 1,428,571 Ordinary Shares respectively. The subscriptions are at a price of 3.5 pence per ordinary share for a total of £60,000. Following these subscriptions, Antony Calamita is now interested in 54,385,714 Ordinary Shares, representing 8.61% of the Company’s share capital as increased by the fundraising, and Andrew Male is now interested in 6,138,196 Ordinary Shares, representing 0.97% of the Company’s issued share capital as increased by the fundraising

Further, the timetable for receipt of applications under the Broker Option, which was also announced yesterday, has been extended until 5:00 pm 9 April 2021 to capture additional interest which was unable to be completed yesterday.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, would like to provide the following dial-in information for the Company’s upcoming Annual and Special Meeting (the “Meeting”) scheduled to be held at 11:00 a.m. Eastern Daylight Time on April 12, 2021. Shareholders and proxyholders may access the Meeting via teleconference by dialing 647-723-3984 or 1-866-365-4406 from Canada or the United States, then entering participation code “8487744” followed by the pound (“#”) sign.

In consideration of the COVID-19 pandemic and the recent restrictions imposed by the Ontario Provincial Government, shareholders and proxyholders will only be able to attend the Meeting via teleconference and will not be permitted to attend the Meeting in person at the address provided on the Notice of Annual and Special Meeting of Shareholders.

Keep reading... Show less

Gage Growth Corp. (“Gage” or the “Company”) (CSE:GAGE), a leading high-quality craft cannabis brand and operator in Michigan, announced today that it has signed an agreement with Blue River™ Extracts & Terpenes (“Blue River™”) to bring the brand’s award-winning solventless technology and other trademark branded products to the state’s medical patients and cannabis consumers. The Company will have exclusive rights to Blue River™’s premium product offerings in Michigan.

Keep reading... Show less